'KovoCloud builds on 20 years of specialist, in-clinic digital healthcare expertise, combined with intensive development by our tech teams,' explains Kovo CEO
'KovoCloud is accelerating the growth of Kovo's SaaS-style AI billing platform, and is the foundation for a new suite of specialized new software offerings including Practice Management, Payment Processing, Electronic Medical Records and
'With the newly accessible medically trained generative AI models, combined with our KovoCloud platform, deep expertise, and rich data sets accumulated over many years, we are in a rare position to deliver practical and reliable AI capabilities to our customers. Even more exciting is the promise of extracting incredible insights to drive better outcomes, enhanced physician experience, and autonomous supports for patients,' says Noble.
KovoCloud: Gamechanger for Small and Medium-Sized Healthcare Providers
KovoCloud is unique in the US and healthcare space where there is a lack of modern RCM and practice software technology solutions for small to medium-sized clinics. KovoCloud is an AI powered, cloud based, HIPAA compliant platform in a field of aging software that does not meet the needs of modern practitioners and patients seeking technology solutions to make manual tasks easier on a daily basis.
'KovoCloud delivers years of real-world billing and practice management experience to healthcare providers in a simple, intuitive experience. On the patient side, KovoCloud is an online engagement platform that was developed with careful thought to digital sensitivity and delivers multiple self-serve functions that empower and enable patients of small and medium-sized healthcare clinics and labs,' explains Kovo Board Chair and e-health innovator Dr.
According to Noble and Chan, Kovo will begin on-boarding existing clients to KovoCloud throughout Fall 2023. The Company anticipates onboarding new clients to KovoCloud by Q4 2023.
About
Contact:
Email: investors@kovo.co
Tel: 1-866-558-6777
Forward-Looking Information and Non-IFRS Measures Statement
This press release may contain 'forward-looking information' and 'forward-looking statements' (collectively, 'forward-looking information') concerning the Company and its subsidiaries within the meaning of applicable securities laws. Forward-looking information may relate to the future financial outlook and anticipated events or results of the Company and may include information regarding the Company's financial position, business strategy, growth strategies, acquisition prospects and plans, addressable markets, budgets, operations, financial results, taxes, dividend policy, plans and objectives. Particularly, information regarding the Company's expectations of future results, performance, achievements, prospects or opportunities or the markets in which the Company operates is forward-looking information. In some cases, forward-looking information can be identified by the use of forward-looking terminology such as 'plans', 'targets', 'expects', 'budgets', 'scheduled', 'estimates', 'outlook', 'forecasts', 'projects', 'prospects', 'strategy', 'intends', 'anticipates', 'believes', or variations of such words and phrases or statements that certain actions, events or results 'may', 'could', 'would', 'might', or 'will' occur. In addition, any statements that refer to expectations, intentions, projections or other characterizations of future events or circumstances contain forward-looking information. Statements containing forward-looking information are not historical facts but instead represent management's expectations, estimates and projections regarding future events or circumstances.
Many factors could cause the Company's actual results, performance, or achievements to be materially different from any future results, performance, or achievements that may be expressed or implied by such forward-looking information, including, without limitation, those listed in the 'Risk Factors' section of the final prospectus of the Company dated
This press release may make reference to certain non-IFRS measures. These measures are not recognized measures under IFRS, do not have a standardized meaning prescribed by IFRS and are therefore unlikely to be comparable to similar measures presented by other companies. Rather, these measures are provided as additional information to complement those IFRS measures by providing further understanding of the Company's results of operations from management's perspective. The Company's definitions of non-IFRS measures used in this release may not be the same as the definitions for such measures used by other companies in their reporting. Non-IFRS measures have limitations as analytical tools and should not be considered in isolation nor as a substitute for analysis of the Company's financial information reported under IFRS. The Company uses non-IFRS financial measures, including 'ARR', 'EBITDA', 'Adjusted EBITDA' and 'Adjusted EBITDA Margin' to provide investors with supplemental measures of its operating performance and to eliminate items that have less bearing on operating performance or operating conditions and thus highlight trends in its core business that may not otherwise be apparent when relying solely on IFRS financial measures. 'EBITDA' means net income (loss) before amortization and depreciation expenses, finance and interest costs, and provision for income taxes. 'Adjusted EBITDA' adjusts EBITDA for stock-based compensation expense, transactional gains or losses on assets, asset impairment charges, interest income, net foreign exchange gains or losses, income tax expense or recovery, forgivable one-time government financial payments related to the COVID-19 pandemic ('PPP Loans'), and any transactional expenses. Specifically, the Company believes that Adjusted EBITDA, when viewed with the Company's results under IFRS and the accompanying reconciliations, provides useful information about the Company's business without regard to potential distortions. By eliminating potential differences in results of operations between periods caused by factors such as depreciation and amortization methods and restructuring, impairment and other charges, the Company believes that Adjusted EBITDA can provide a useful additional basis for comparing the current performance of the underlying operations being evaluated. The term Annual Recurring Revenue ('ARR') is a non-IFRS measure and refers to multiplying the monthly revenue for a current month by twelve. ARR is a metric typically used by recurring revenue companies to communicate run rate at a specific moment in time The Company believes that securities analysts, investors and other interested parties frequently use non-IFRS financial measures in the evaluation of issuers. The Company's management also uses non-IFRS financial measures in order to facilitate operating performance comparisons from period to period.
(C) 2023 Electronic News Publishing, source